Erythropoietin

a review.

D. M. Ridley, F. Dawkins, E. Perlin

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

The fact that a plasma factor was responsible for the stimulation of red cell production has been known for more than 35 years. However, it is only recently that the gene responsible for its production and its molecular structure has been identified. Furthermore, recombinant human erythropoietin is now available for clinical use. This article details the molecular biology and clinical pharmacology of this remarkable growth factor.

Original languageEnglish (US)
Pages (from-to)129-135
Number of pages7
JournalJournal of the National Medical Association
Volume86
Issue number2
StatePublished - Feb 1 1994
Externally publishedYes

Fingerprint

Clinical Pharmacology
Erythropoietin
Molecular Structure
Molecular Biology
Intercellular Signaling Peptides and Proteins
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ridley, D. M., Dawkins, F., & Perlin, E. (1994). Erythropoietin: a review. Journal of the National Medical Association, 86(2), 129-135.

Erythropoietin : a review. / Ridley, D. M.; Dawkins, F.; Perlin, E.

In: Journal of the National Medical Association, Vol. 86, No. 2, 01.02.1994, p. 129-135.

Research output: Contribution to journalReview article

Ridley, DM, Dawkins, F & Perlin, E 1994, 'Erythropoietin: a review.', Journal of the National Medical Association, vol. 86, no. 2, pp. 129-135.
Ridley DM, Dawkins F, Perlin E. Erythropoietin: a review. Journal of the National Medical Association. 1994 Feb 1;86(2):129-135.
Ridley, D. M. ; Dawkins, F. ; Perlin, E. / Erythropoietin : a review. In: Journal of the National Medical Association. 1994 ; Vol. 86, No. 2. pp. 129-135.
@article{322a8af0c09446d4abc816059a9f85e6,
title = "Erythropoietin: a review.",
abstract = "The fact that a plasma factor was responsible for the stimulation of red cell production has been known for more than 35 years. However, it is only recently that the gene responsible for its production and its molecular structure has been identified. Furthermore, recombinant human erythropoietin is now available for clinical use. This article details the molecular biology and clinical pharmacology of this remarkable growth factor.",
author = "Ridley, {D. M.} and F. Dawkins and E. Perlin",
year = "1994",
month = "2",
day = "1",
language = "English (US)",
volume = "86",
pages = "129--135",
journal = "Journal of the National Medical Association",
issn = "1943-4693",
publisher = "National Medical Association",
number = "2",

}

TY - JOUR

T1 - Erythropoietin

T2 - a review.

AU - Ridley, D. M.

AU - Dawkins, F.

AU - Perlin, E.

PY - 1994/2/1

Y1 - 1994/2/1

N2 - The fact that a plasma factor was responsible for the stimulation of red cell production has been known for more than 35 years. However, it is only recently that the gene responsible for its production and its molecular structure has been identified. Furthermore, recombinant human erythropoietin is now available for clinical use. This article details the molecular biology and clinical pharmacology of this remarkable growth factor.

AB - The fact that a plasma factor was responsible for the stimulation of red cell production has been known for more than 35 years. However, it is only recently that the gene responsible for its production and its molecular structure has been identified. Furthermore, recombinant human erythropoietin is now available for clinical use. This article details the molecular biology and clinical pharmacology of this remarkable growth factor.

UR - http://www.scopus.com/inward/record.url?scp=0028373835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028373835&partnerID=8YFLogxK

M3 - Review article

VL - 86

SP - 129

EP - 135

JO - Journal of the National Medical Association

JF - Journal of the National Medical Association

SN - 1943-4693

IS - 2

ER -